Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Infection and Drug Resistance|February 19, 2021
Detection of gyrA and parC Mutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in <i>Klebsiella pneumoniae</i>Sawsan Mohammed Kareem, Israa M S Al-Kadmy, Saba S Kazaal, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|September 10, 2019
Impact of <i>Ginkgo biloba</i> extract and magnetized water on the survival rate and functional capabilities of pancreatic β-cells in type 2 diabetic rat modelAhmed Saleh, Mamdouh M Anwar, Ahmed E Zayed, et al.
Veterinary Research Communications|May 2, 2025
Mycological and molecular identification of mycoses involved in mastitis from Holstein dairy cattle with special reference to Candida albicansHayat Fayed, Asmaa A Elgendy, Salma A Shoulah, et al.
Scientific Reports|January 15, 2021
The potential ameliorative impacts of cerium oxide nanoparticles against fipronil-induced hepatic steatosisLamiaa Wasef, Atef M K Nassar, Yasser S El-Sayed, et al.
Molecules (Basel, Switzerland)|August 6, 2020
Chemo-Protective Potential of Cerium Oxide Nanoparticles against Fipronil-Induced Oxidative Stress, Apoptosis, Inflammation and Reproductive Dysfunction in Male White Albino RatsHamida Saleh, Atef M K Nassar, Ahmed E Noreldin, et al.
Frontiers in Medicine|May 3, 2021
Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19Gaber El-Saber Batiha, Marwa A Zayed, Aya A Awad, et al.
Scientific Reports|October 8, 2025
Time-dependent expression of neural oxidative and inflammatory biomarkers in ischemic stroke using a transient MCAO rat modelOla Habotta, Ahmed Abdeen, Basma M Hendam, et al.
Scientific Reports|June 21, 2022
COVID-19 associated mucormycosis in Assiut University Hospitals: a multidisciplinary dilemmaSahar Farghly Youssif, Marwa M Abdelrady, Ahmed Atef Thabet, et al.
Diseases (Basel, Switzerland)|August 27, 2025
Safety and Efficacy of Immune Checkpoint Inhibitors in Human Immunodeficiency Virus-Associated Cancer: A Systematic Scoping ReviewAhmed D Alatawi, Amirah B Alaqyl, Reema J Alalawi, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-AnalysisHelal F Hetta, Ayman Salama, Turki A Aljuaid, et al.
Pageof 23